In addition, repeated intravenous T22-DITOX-H6 administration in the CXCR4+ EC AN3CA orthotopic model induced a potent antimetastatic effect by displaying a reduction in primary tumor growth, and a blockage of metastasis development, again without systemic toxicity. This evidence concerns the gene CXCR4 and neoplasm.